Global Transcatheter Embolization and Occlusion Devices Market Size, Trends, and Growth Opportunity, By Product (Coiled Devices, Non-Coiled Devices), By Application (Peripheral Vascular Disease, Oncology), By End-Users (Hospitals and Clinics, Ambulatory Surgery Centers), By Region and Forecast to 2030.
Global Transcatheter Embolization and Occlusion Devices Market
The Global Transcatheter Embolization and Occlusion Devices Market was valued at USD 5.10 billion in 2022 and is expected to reach USD 13.47 billion by 2030, at a CAGR 3.84% during the forecast period 2023- 2030.
Devices known as transcatheter embolization and occlusion devices are used in interventional radiology to block blood flow to a tumor or other part of the body by injecting a catheter-based synthetic embolus into the blood vessel. Chemotherapeutic medicines are coated on embolic agents to attack the tumor by blocking the blood supply and inducing cytotoxicity. With little tissue discomfort and smaller incisions, this procedure serves as an alternative to open surgery. A synthetic embolus is inserted or put through a tiny catheter during a minimally invasive (MI) treatment known as transcatheter embolization and occlusion (TEO) in interventional radiology.
Market Drivers
One of the primary factors propelling the expansion of the transcatheter embolization and occlusion market is the rise in the incidence of chronic diseases among people around the world. The widespread usage of these devices helps prevent problems with coiling, such as inaccurate deployment, catheter entrapment, and balloon deflation, and there has been a trend towards non-coil devices to take advantage of the advantages and further impact the market.
The market is also impacted by regional government initiatives to strengthen the manufacturing sector and healthcare facilities as well as the prevalence of risk factors like obesity, bad eating patterns, and alcohol and cigarette use. The transcatheter embolization and occlusion market is also benefited from the benefits of minimally invasive therapy, the rise in healthcare spending, and the aging population.
Market Restraints
High product costs will impede market expansion during the forecast period. In the coming years, the transcatheter embolization and occlusion market is anticipated to face challenges due to the existence of a strict regulatory framework for product commercialization.
Market Segmentation
The Global Transcatheter Embolization and Occlusion Devices Market is segmented into Products, Applications, and End-Users.
Based on Product, the market is divided into Coiled Devices, Non-Coiled Devices.
Based on Application, the market is segmented into Peripheral Vascular Disease, Oncology.
Based on End-Users, the market is divided into Hospitals and Clinics, Ambulatory Surgery Centers.
Regional Analysis
 
The Global Transcatheter Embolization and Occlusion Devices Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.
Over the forecast period, North America is anticipated to rule the Transcatheter Embolization and Occlusion Devices market. The US government's increased healthcare spending, improved reimbursement policies, easier accessibility, and high acceptance of technological improvements are to blame for this dominance. Also, the United States is the largest market in the world with the most advanced healthcare infrastructure. The market is expected to grow as a result of increasing product launches and commercialization partnerships between key manufacturers and other businesses.
Key Players
Various key players are discussed in the Global Transcatheter Embolization and Occlusion Devices Market Report including: BTG plc, Boston Scientific Corporation, Medtronic plc, Penumbra, Inc, Cook Medical, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc., Pfizer Inc., Stryker Corporation, Terumo Corporation, Cordis Corporation.
For instance, Abbott's Amplatzer steerable delivery sheath was given the CE mark and Health Canada certification in June 2021. The Amplatzer sheath, according to the manufacturer, is the first steerable delivery sheath designed specifically for patients undergoing minimally invasive left atrial appendage (LAA) occlusion (or closure) procedures. This is expected to drive the market for Transcatheter Embolization and Occlusion Devices to grow.

Market Taxonomy
By Product 
• Coiled Devices 
• Non-Coiled Devices
By Application 
• Peripheral Vascular Disease
• Oncology
By End-Users 
• Hospitals and Clinics
• Ambulatory Surgery Centers 
By Region

• North America 
• Latin America 
• Europe  
• Asia Pacific  
• Middle East & Africa

Global Transcatheter Embolization and Occlusion Devices Market
1 Introduction 
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Transcatheter Embolization and Occlusion Devices Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn 
4.2.6 Post covid-19 world Supply & Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Transcatheter Embolization and Occlusion Devices Market, By Product 
5.1 Y-o-Y Growth Comparison, By Product  
5.2 Global Transcatheter Embolization and Occlusion Devices Market Share Analysis, By Product  
5.3 Global Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By Product 
5.3.1 Coiled Devices
5.3.2 Non-Coiled Devices
6 Global Transcatheter Embolization and Occlusion Devices Market, By Application
6.1 Y-o-Y Growth Comparison, By Product
6.2 Global Transcatheter Embolization and Occlusion Devices Market Share Analysis, By Application
6.3 Global Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By Application
6.3.1 Peripheral Vascular Disease
6.3.2 Oncology
7 Global Transcatheter Embolization and Occlusion Devices Market, By End-Users 
7.1 Y-o-Y Growth Comparison, By End-Users 
7.2 Global Transcatheter Embolization and Occlusion Devices Market Share Analysis, By End-Users 
7.3 Global Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By End-Users 
7.3.1 Hospitals and Clinics
7.3.2 Ambulatory Surgery Centers
8 Global Transcatheter Embolization and Occlusion Devices Market, By Region
8.1 Global Transcatheter Embolization and Occlusion Devices Market Share Analysis, By Region
8.2 Global Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By Region
9 North America Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast (2022-2030)
9.1 Introduction
9.2 North America Transcatheter Embolization and Occlusion Devices Market Share Analysis, By Product  
9.3 North America Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By Application 
9.4 North America Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By End-Users 
9.5 North America Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast (2022-2030)
10.1 Introduction
10.2 Europe Transcatheter Embolization and Occlusion Devices Market Share Analysis, By Product  
10.3 Europe Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By Application
10.4 Europe Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By End-Users 
10.5 Europe Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast (2022-2030)
11.1 Introduction
11.2 Asia Pacific Transcatheter Embolization and Occlusion Devices Market Share Analysis, By Product  
11.3 Asia Pacific Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By Application
11.4 Asia Pacific Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By End-Users 
11.5 Asia Pacific Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By Country
11.5.1 China 
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast (2022-2030)
12.1 Introduction
12.2 Latin America Transcatheter Embolization and Occlusion Devices Market Share Analysis, By Product  
12.3 Latin America Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By Application
12.4 Latin America Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By End-Users 
12.5 Latin America Transcatheter Embolization and Occlusion Devices Market Size and Forecast, Country
12.5.1 Brazil
12.5.2 Rest of Latin America
13 Middle East Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast (2022-2030)
13.1 Introduction
13.2 Middle East Transcatheter Embolization and Occlusion Devices Market Share Analysis, By Product  
13.3 Middle East Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By Application
13.4 Middle East Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By End-Users 
13.5 Middle East Transcatheter Embolization and Occlusion Devices Market Size and Forecast, By Country
13.6.1 Saudi Arabia
13.5.2 UAE
13.5.3 Egypt
13.5.4 Kuwait
13.5.5 South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 BTG plc
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Boston Scientific Corporation
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Medtronic plc
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Penumbra, Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Cook Medical
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Edwards Lifesciences Corporation
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Johnson & Johnson Services, Inc.
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Pfizer Inc.
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Stryker Corporation
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Terumo Corporation
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies